ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1296

Quantitative Measurements of Cartilage, Osteophyte, and Bone Marrow Lesion Volume in Knee Osteoarthritis

Lena Franziska Schaefer1, Ming Yin1, Meera Sury2, Scott Jamieson1, Jamie E. Collins3, Stacy Smith4 and Jeffrey Duryea1, 1Radiology, Brigham & Women's Hospital/ Harvard Medical School, Boston, MA, 2Brigham & Women's Hospital/ Harvard Medical School, Boston, MA, 3Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopedic Surgery, Brigham & Women's Hospital, Boston, MA, 4Radiology/Division of Musculoskeletal Imaging & Intervention, Brigham & Women's Hospital/ Harvard Medical School, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Imaging, Knee and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Imaging of Rheumatic Diseases - Poster II: XR/CT/PET/MRI

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Quantitative Measurements of Cartilage, Osteophyte, and Bone Marrow Lesion volume in Knee Osteoarthritis

Schaefer L.F., Yin M., Sury, M., Jamieson S., Collins J., Smith S., Duryea J.

Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

Background/Purpose: Clinical trials and other large studies of knee osteoarthritis (OA) require efficient and objective methods to assess disease changes. Magnetic resonance imaging (MRI) offers superb soft tissue contrast and is ideal for visualizing many structures associated with knee OA. We have developed the MRI Osteoarthritis Software Score (MOSS), a software-based method that assesses volume change of osteophytes, cartilage, and bone marrow lesions (BMLs) for knee OA. The goal of our study is to assess all 600 subjects of the OA Biomarkers Consortium FNIH Study. This will further validate the method and demonstrate its suitability for use in highly-powered studies and clinical trials of knee OA.

Methods: The OA Biomarkers Consortium FNIH Study is a case-control study of knee OA progression nested within the Osteoarthritis Initiative (OAI). The study cohort was divided into four subgroups based on radiographic and pain progression: Group 1: radiographic and pain progression (n=194) Group 2: radiographic-only progression (n=103) Group 3: pain-only progression (n=103) Group 4: no radiographic or pain progression (n=200). Double echo steady state (DESS) pulse sequences were used for cartilage and osteophytes, and turbo spin echo (TSE) for BMLs. Baseline to 24 month volume change was analyzed as a predictor of case-control status in univariate models using logistic regression. This highly-powered longitudinal study represents the result of 3,600 individual measurements of OA structures on MRI scans.

Results:   Change in volume of cartilage and osteophytes were strongly associated with radiographic progression: decreasing cartilage volume was associated with an increased odds of being a case, while increasing osteophyte and BML volume were associated with an increased odds of being a case. The association of cartilage and osteophyte volume change was lower but significant for pain progression. BMLs showed marginally significant associations with radiographic and pain progression. All three measurements (cartilage, osteophytes, and BMLs) can be performed in a total time of less than 30 minutes per knee, split roughly evenly between a research assistant and an experienced reader. Table 1: Results  

Primary analysis: cases (Group 1) versus controls (Group 2, 3, and 4) Radiographic (Group 1+2) versus non-radiographic progression (Group 3+4) Pain progression (Group 1+3) versus no pain progression (Group 2+4)
Variable Adjusted OR (95% CI) p-value Adjusted OR (95% CI) p-value Adjusted OR (95% CI) p-value
Cartilage 0.55 (0.45-0.67) <.0001 0.30 (0.22-0.39) <.0001 0.75 (0.63-0.90) 0.0018
Osteophytes 1.53 (1.27-1.85) <.0001 2.13 (1.69-2.69) <.0001 1.21 (1.02-1.45) 0.0329
Bone Marrow Lesions 1.25 (1.04-1.49)  0.0169   1.23 (1.02-1.48) 0.0285   1.21 (1.01-1.44) 0.0375 

Conclusion: We have demonstrated that measurements of cartilage, BML, and osteophyte volume using the MOSS method have clinical validity in a case-control study. The method is efficient and ideal for current and future large studies and clinical trials of knee OA requiring assessment of many thousands of MRI scans.  


Disclosure: L. F. Schaefer, None; M. Yin, None; M. Sury, None; S. Jamieson, None; J. E. Collins, None; S. Smith, None; J. Duryea, None.

To cite this abstract in AMA style:

Schaefer LF, Yin M, Sury M, Jamieson S, Collins JE, Smith S, Duryea J. Quantitative Measurements of Cartilage, Osteophyte, and Bone Marrow Lesion Volume in Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/quantitative-measurements-of-cartilage-osteophyte-and-bone-marrow-lesion-volume-in-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantitative-measurements-of-cartilage-osteophyte-and-bone-marrow-lesion-volume-in-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology